Thienopyrimidinediones and their use in the modulation of autoimmune disease

Details for Australian Patent Application No. 2004206012 (hide)

Owner AstraZeneca AB

Inventors Guile, Simon David

Agent Freehills

Pub. Number AU-B-2004206012

PCT Pub. Number WO2004/065394

Priority 0300119-5 17.01.03 SE

Filing date 15 January 2004

Wipo publication date 5 August 2004

Acceptance publication date 14 June 2007

International Classifications

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

Event Publications

11 August 2005 PCT application entered the National Phase

  PCT publication WO2004/065394 Priority application(s): WO2004/065394

14 June 2007 Application Accepted

  Published as AU-B-2004206012

11 October 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004206028-Bag sealing system and method

2004206011-Thienopyridazinones and their use in modulation of autoimmune disease